PeptideBase
Back to Database
evidence varies by claim

TE-8105

TE-8105

Metabolic & Endocrine

TE-8105 is indexed as peptide in the PeptideBase article library. It is referenced in “TE-8105: What a 38-Person First-in-Human Long-Acting GLP-1 Trial Actually Shows”. This page groups the relevant coverage; evidence strength, safety, and clinical relevance depend on the specific claim and source.

Research status: evidence varies by claim

Deep Dives on TE-8105

Start here for the plain-English articles connected to this peptide.

Research & Evidence8 min read

TE-8105: What a 38-Person First-in-Human Long-Acting GLP-1 Trial Actually Shows

TE-8105 had an approximately 120-hour half-life in a 38-person open-label Phase 1 study. Here is what that finding—and the early weight and safety observations—can and cannot establish.

Read article

Quick Facts

Origin
Named peptide referenced in PeptideBase coverage
Category
Metabolic & Endocrine

Research Areas

Research & Evidence

Tags

te-8105peptidenamed peptide